RxDoctor Payments Data

Heather Matthews, PA

Physician Assistant · Kinston, NCNPI 1477538098

Payments from drug & device makers

$6,418in general payments, 2019–2025

Across 408 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$883
  • Novo Nordisk$817
  • Novartis$692
  • Bayer$539
  • AstraZeneca$477
  • Amgen$324
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,418100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,418 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$79,903
Medicare patients
128
Services billed
2,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin128$107,366
OzempicSemaglutide28$36,056
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$34,329
EliquisApixaban26$26,335
TrintellixVortioxetine Hydrobromide24$11,709
LinzessLinaclotide18$9,935
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,176
JanuviaSitagliptin Phosphate11$7,559
XareltoRivaroxaban12$6,851
PremarinEstrogens, Conjugated18$5,289
Albuterol Sulfate HfaAlbuterol Sulfate138$2,859
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,685
Omeprazole211$2,402
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,349
BystolicNebivolol Hcl11$1,894

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$202$107,366128 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix$883$45,19080 claims
Novo NordiskOzempic$817$36,05628 claims
PfizerEliquis, Premarin$113$31,62444 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$87$11,70924 claims
AbbVieLinzess$229$9,93518 claims
MerckJanuvia$97$7,55911 claims
Johnson & JohnsonXarelto$65$6,85112 claims
Kowa Pharmaceuticals America, Inc.Bystolic$40$1,89411 claims
Scilex Pharmaceuticals Inc.Colchicine$25$78424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Kinston

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →